We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
B.p. Marsh & Partners Plc | LSE:BPM | London | Ordinary Share | GB00B0XLRJ79 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
15.00 | 3.12% | 496.00 | 494.00 | 498.00 | 496.00 | 481.00 | 481.00 | 38,735 | 16:23:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | 32.57M | 23.84M | 0.6408 | 7.74 | 184.56M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/7/2018 08:18 | Phoned Interactive In. about it and they have told me that it may be close of business today to correct share prices/ allocations. R. | retsius | |
09/7/2018 07:33 | With Hargreaves Lansdown - money was 'deducted'/held from last week, at the value of full application including excess. Still showing the same - despite update re: approx. 3% for application in excess of basic entitlement | jafvfn | |
09/7/2018 07:26 | Does anyone see their portfolio credited with new shares? At the moment money has been deducted for buying them but shows 'no value' R. | retsius | |
08/7/2018 07:10 | I complained by email to the Investor Relations Director, Camilla Kenyon and received an almost instant courteous response - pretty good, early on a Sunday morning. It does not change anything and I remain disappointed with a 3 percent allocation, but made my point. | amwel44 | |
07/7/2018 17:25 | Yes that is correct. Not sure of the details. Broker A All the holders apply for their open offer allocation plus the surplus so get the minimum excess Broker B Some holders don't apply for open offer or surplus so in theory the broker can reallocate their possible shares to the other shareholders who do apply for excess shares. Assuming the broker can be bothered. Nice of BPM to allow small shareholders to participate. But PSC Insurance Group ends up with 19.6% | jagworth | |
07/7/2018 16:15 | Shares applied for up to 1/21 of your original holding will be received in full plus 3% of any shares applied for in excess of that however, depending on your broker, i'm guessing that some may receive more than 3% please correct me if wrong | spob | |
07/7/2018 14:58 | I asked for a few to make the holding with the OO up to round number. I think small applications should have been met in full. | bscuit | |
07/7/2018 13:58 | Anyone got any thoughts how the share price will react on Monday? I have absolutely none?! R. | retsius | |
06/7/2018 10:15 | I applied to double my holding. Didn’t expect to get 100% but thought I would get more than a pathetic 3% Oh well never mind. If it’s only going to be 3%, I may as well keep them :) | spob | |
06/7/2018 09:18 | Get a tiny amount of excess application , just 3%, the small investor always gets a poor deal. | its the oxman | |
05/7/2018 20:34 | if you've applied for the excess entitlement, when do you find out how many shares you will be awarded ? will it be tomorrow morning ? | spob | |
20/6/2018 20:28 | Lets hope that LEBC does indeed IPO next year. | gargleblaster | |
20/6/2018 18:19 | Fabulous figures from Lebc today, what's not to like? Only way is up! R. | retsius | |
20/6/2018 17:59 | thanks Spob. lets see how it pans out. | srtoothpaste | |
20/6/2018 15:22 | Investee Company Update - LEBC LEBC REPORTS STRONG GROWTH IN UNDERLYING PROFIT The Company notes that its Investee Company LEBC Holdings Limited ("LEBC"), in which it holds a 59.34% shareholding, has today announced its interim results for the six months to 31 March 2018. During the period LEBC's revenue grew 20.7% to GBP10.2m (2017: GBP8.5m) and trading profit grew 95.3% to GBP2.4m (2017: GBP1.2m). These figures do not include Aspira the acquisition that LEBC completed in February 2018. LEBC noted that much of this success was largely driven by the growth of its "bionic advice" proposition and offering at-retirement advice to large defined benefit schemes. Jack McVitie, chief executive of LEBC said: "The Company is uniquely positioned to take advantage of important trends that are driving the need for lower cost regulated advice. Looking ahead, our unique business model, coupled with our strong management team and financial and operational discipline, places us particularly well for future market opportunities." Camilla Kenyon, the Company's representative on the LEBC Board, commented: "This strong set of Interim Figures demonstrates LEBC's robust trajectory and bright prospects." For further information please contact: B.P. Marsh & Partners Plc www.bpmarsh.co.uk | spob | |
20/6/2018 07:40 | Corporate activity to boost BP Marsh Simon Thompson, Investors Chronicle 12 June 2018 I have had a results call this morning with Brian Marsh, chairman of insurance sector investment company BP Marsh & Partners (BPM:284p). It’s a company I know well, having first advised buying the shares at 88p ('Hyper value small-cap buy', 22 Jan 2012), and last reiterated that advice at 260p (‘Investment company watch’, 12 Feb 2018). It proved the right call as BP Marsh has just reported a 24 per cent increase in its net asset value (NAV) to £98.9m, or 339p a share, in the year to the end of January 2018. The drivers of the stellar investment performance came from two of the company’s largest shareholdings: LEBC, an independent financial advisory firm that has been generating explosive earnings growth from developing its traditional advice model and growing corporate project work; and Nexus Underwriting, an independent speciality managing general agency that has been making some shrewd acquisitions to scale up the operation. BP Marsh’s valuation committee believes LEBC’s equity is now worth £56m, or 80 per cent higher than its valuation 12 months earlier, implying a value of £33.1m on BP Marsh’s 59.3 per cent stake. The uplift looks justified. Having reported a 42 per cent rise in trading profit to £3m on revenue up 17 per cent to £18.1m in the 12 months to the end of September 2017, LEBC is “trading significantly ahead of last year”. Moreover, I understand that LEBC “is looking to IPO on the London Stock Market next year”, which could bring another windfall gain for BP Marsh. It gets better because BP Marsh’s 17 per cent stake in Nexus is worth £20.5m, up from £13.9m 12 months earlier, which values the equity in that company at £120m. However, a well informed report in Insurance Insider last week suggests that private equity houses have been running their rule over Nexus and have valued the business at closer to £180m, or 18 times its 2017 reported cash profit. Hyperion Insurance sold its majority stake in CFC Underwriting to a consortium of private investors and the management team on a multiple of 22 times cash profits, so the exit multiples being bandied around for Nexus don’t seem out of place. The potential for corporate activity aside, BP Marsh has a new 19.6 per cent shareholder, Australian Stock Exchange-listed PSC Insurance. PSC is acquiring £15.5m of new shares in a placing at 252p a share, and just shy of £3m of stock from Mr Marsh, who will still own a 44 per cent stake. BP Marsh is raising a further £1.5m at the same price through a one-for-21 open offer to existing shareholders. The new funds will be used by BP Marsh to fund new investments. More importantly, PSC is looking to enter into the US insurance market, so having a large investor on side should help accelerate and add value to both of BP Marsh’s US holdings: Mark Edwards Partners, and XPT. These have a combined value of £8.4m. BP Marsh's existing shareholders subscribing for the open offer will also receive the final dividend of 4.76p a share, up 27 per cent year on year. With the investment risk to both LEBC and Nexus skewed firmly to the upside, I rate the shares a buy and have a new target price of 339p to reflect the real prospect of a realisation of value from both holdings to send BP Marsh’s NAV surging again. Buy. | spob | |
19/6/2018 14:05 | Corporate activity to boost BP Marsh Simon Thompson, Investors Chronicle 12 June 2018 I have had a results call this morning with Brian Marsh, chairman of insurance sector investment company BP Marsh & Partners (BPM:284p). It’s a company I know well, having first advised buying the shares at 88p ('Hyper value small-cap buy', 22 Jan 2012), and last reiterated that advice at 260p (‘Investment company watch’, 12 Feb 2018). It proved the right call as BP Marsh has just reported a 24 per cent increase in its net asset value (NAV) to £98.9m, or 339p a share, in the year to the end of January 2018. The drivers of the stellar investment performance came from two of the company’s largest shareholdings: LEBC, an independent financial advisory firm that has been generating explosive earnings growth from developing its traditional advice model and growing corporate project work; and Nexus Underwriting, an independent speciality managing general agency that has been making some shrewd acquisitions to scale up the operation. BP Marsh’s valuation committee believes LEBC’s equity is now worth £56m, or 80 per cent higher than its valuation 12 months earlier, implying a value of £33.1m on BP Marsh’s 59.3 per cent stake. The uplift looks justified. Having reported a 42 per cent rise in trading profit to £3m on revenue up 17 per cent to £18.1m in the 12 months to the end of September 2017, LEBC is “trading significantly ahead of last year”. Moreover, I understand that LEBC “is looking to IPO on the London Stock Market next year”, which could bring another windfall gain for BP Marsh. It gets better because BP Marsh’s 17 per cent stake in Nexus is worth £20.5m, up from £13.9m 12 months earlier, which values the equity in that company at £120m. However, a well informed report in Insurance Insider last week suggests that private equity houses have been running their rule over Nexus and have valued the business at closer to £180m, or 18 times its 2017 reported cash profit. Hyperion Insurance sold its majority stake in CFC Underwriting to a consortium of private investors and the management team on a multiple of 22 times cash profits, so the exit multiples being bandied around for Nexus don’t seem out of place. The potential for corporate activity aside, BP Marsh has a new 19.6 per cent shareholder, Australian Stock Exchange-listed PSC Insurance. PSC is acquiring £15.5m of new shares in a placing at 252p a share, and just shy of £3m of stock from Mr Marsh, who will still own a 44 per cent stake. BP Marsh is raising a further £1.5m at the same price through a one-for-21 open offer to existing shareholders. The new funds will be used by BP Marsh to fund new investments. More importantly, PSC is looking to enter into the US insurance market, so having a large investor on side should help accelerate and add value to both of BP Marsh’s US holdings: Mark Edwards Partners, and XPT. These have a combined value of £8.4m. BP Marsh's existing shareholders subscribing for the open offer will also receive the final dividend of 4.76p a share, up 27 per cent year on year. With the investment risk to both LEBC and Nexus skewed firmly to the upside, I rate the shares a buy and have a new target price of 339p to reflect the real prospect of a realisation of value from both holdings to send BP Marsh’s NAV surging again. Buy. | spob | |
15/6/2018 10:04 | Any chance of posting highlights of the Simon T write up here? I tried to buy the magazine today but my local WH Smith doesn't have the new edition yet! | danielbird193 | |
12/6/2018 11:20 | Simon T. Excellent appraisal of results in the IC.(10 min ago.) Poss. IPO of LEBC next year. New target price of 339p. BUY. R. | retsius | |
12/6/2018 11:17 | All looks positive re growth of the business but guess the share price will - as happens with most placings slip back temporarily , may be a short term blip and create an opportunity to add in the days ahead. | its the oxman | |
12/6/2018 06:58 | AND a placing and offer at 7.54 am..... | cwa1 | |
12/6/2018 06:56 | 7.51 release? Cutting it fine. Somebody sleep in?! FINAL RESULTS FOR THE YEAR TO 31 JANUARY 2018 B.P. Marsh & Partners Plc (AIM: BPM), the niche venture capital provider to early stage financial services businesses, announces its audited Group final results for the year to 31 January 2018. The highlights of the results are: -- Increase in the Equity Value of the Portfolio of 31.3% (GBP18.9m) -- Net Asset Value of GBP98.9m (31 January 2017: GBP79.7m), a 24.1% increase, net of Dividend -- Net Asset Value increased to 339p per share (31 January 2017: 273p) -- Total return to Shareholders in the year of 25.5% (2017: 13.9%) -- Consolidated profit after tax of GBP20.2m (31 January 2017: GBP9.8m) -- Average Net Asset Value annual compound growth rate of 12.0% since 1990 -- Final Dividend of 4.76p per share declared (31 January 2017: 3.76p), a 27% increase -- Cash and treasury funds balance of GBP5.4m at year end -- Four new investments - two in Lloyd's Brokers and two in the USA -- Two disposals - Besso and Trireme -- Further investment into LEBC of GBP7.1m -- Provision of follow-on funding to Nexus of GBP4m -- Current uncommitted cash of GBP0.5m "On the conclusion of an excellent year, the Group is in a sound financial position, has a strong portfolio of investments and a management team committed to driving our business forward. The Group is growing strongly, delivering consistent year on year returns to shareholders and is well-positioned to deal with any uncertainty arising from the UK's exit from the EU by April 2019. The Board looks forward to the year ahead with confidence." | cwa1 | |
09/6/2018 13:01 | Any views on next week's figures? BB seems abnormally quiet!? R. | retsius |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions